---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-102245"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-09-22T21:01:01+00:00"
generated_at: "2026-09-22T21:02:09.920668+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tessera Defense closes 10% MEA purchase, lifts stake to 15%, adds $475K convertible loan

## Summary
- Closed Sept 16, 2026 purchase of 324,573 MEA shares (10% fully diluted) for 130,000 HLSQ shares; reverse-split adjusted.
- Amendment raises purchased interest to 486,860 shares (15%), with 65,000 additional shares pending NYSE American listing approval.
- New unsecured convertible loan facility up to $475,000 at 12% interest, maturing 2nd anniversary of closing, convertible at lower of 4x FY2027 EBITDA or $10M valuation.
- Technology License Agreement grants Tessera perpetual, royalty-free, exclusive UAV testing license to MEA patents and dynamometer tech.
- Option to buy Motomova's remaining MEA interest unchanged, exercisable through June 30, 2028, based on FY2027 audited results.

## SEC filing metadata
- accession: 0001213900-26-102245
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-09-22T21:01:01+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026102245/0001213900-26-102245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026102245/ea0305719-8k_tessera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-102245
- JSON: https://secwatch.observer/filing/0001213900-26-102245.json
- Plain text: https://secwatch.observer/filing/0001213900-26-102245.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
